CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.

With that said, here are the 11 Best Genomics Stocks to Buy According to Hedge Funds.

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the best NASDAQ stocks under $50 to buy. Analysts at H.C. Wainwright have ...

Tras obtener recientes aprobaciones en la Unión Europea, el Reino Unido, Japón y Australia, Andembry de CSL ha sido ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

While commercial uptake by patients still lags and a recent court decision rekindles a legal battle, clinical successes continue.

Intellia Therapeutics Inc. stock grades by Barron's. View NTLA fundamental and sentiment analysis powered by MarketGrader.

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of gene editing technology, leveraging its proprietary CRISPR/Cas9 platform to develop potentially transformative therapies for ...